Clean nourishing granules from a subsidiary of Shanghai Pharmaceutical (601607.SH) were approved to carry out clinical trials

Zhitongcaijing · 2d ago

Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) issued an announcement. Recently, the “Clean Nourishing Granules” developed by the Shanghai Pharmaceutical Group Traditional Chinese Medicine Research Institute Co., Ltd. (“Shanghai Pharmaceutical Institute”), a subsidiary of the company, received the “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration. Clean Nourish Granules are developed by changing the process and dosage form on the basis of the in-hospital preparation Qingyun Nourishing Oral Liquid at the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine. The project was developed by the Shanghai Institute of Traditional Chinese Medicine in cooperation with the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine and other organizations, and has core intellectual property rights. The drug is intended to conduct clinical trials for dry eyes.